Sofia Michael J.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$1.9M

Insider Activity of Sofia Michael J.

According to the SEC Form 4 filings, Sofia Michael J., being in a position of

  1. Chief Scientific Officer at Arbutus Biopharma Corporation,
    оver the last 12 months, has bought 0 shares, and sold 9982 shares for $23,083,
    over all time since 2017-08-15, has bought 0 shares, and sold 344232 shares for $1.9M.

The largest sale of all time was on 2021-12-01 and amounted to 200000 shares of Arbutus Biopharma Corporation for $1.02M.

Biography of Sofia Michael J.

No biography is available at this moment.

2024-02-02SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
9,982
0.0056%
$2.31$23,083+26.47%
2021-12-01SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
200,000
0.218%
$5.09$1.02M-44.14%
2018-08-13SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
4,250
0.0076%
$9.51$40,436-60%
2018-07-11SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
10,000
0.017%
$10.00$100,000-61.98%
2018-07-09SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
10,000
0.0183%
$8.91$89,060-53.41%
2018-07-06SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
10,000
0.0166%
$8.45$84,500-55.27%
2018-07-05SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
10,000
0.0167%
$8.40$84,000-54.73%
2018-07-03SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
10,000
0.0174%
$8.00$80,000-50.24%
2017-10-03SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
20,000
0.0392%
$8.00$160,000-21.85%
2017-08-15SaleArbutus Biopharma Corporation
ABUS
Chief Scientific Officer
60,000
0.1079%
$3.70$222,000+51.33%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.